Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1987-7-21
|
pubmed:abstractText |
Thirty-seven patients participating in a controlled treatment study with imipramine were classified as high or low depressed simultaneously on two depression measures. Analysis of variance by 2 (high-low depressed) X 2 (high-low imipramine dosage) groupings revealed significant dose but no depression main effects. The greater dose effect observed in the low depressed group and the greater response rates found among high-dose patients with low initial depression strongly suggest that the beneficial effect of imipramine in agoraphobia was not primarily antidepressant in nature.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0022-3018
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
175
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
358-61
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3295112-Agoraphobia,
pubmed-meshheading:3295112-Clinical Trials as Topic,
pubmed-meshheading:3295112-Depression,
pubmed-meshheading:3295112-Depressive Disorder,
pubmed-meshheading:3295112-Dose-Response Relationship, Drug,
pubmed-meshheading:3295112-Humans,
pubmed-meshheading:3295112-Imipramine,
pubmed-meshheading:3295112-Phobic Disorders,
pubmed-meshheading:3295112-Psychiatric Status Rating Scales
|
pubmed:year |
1987
|
pubmed:articleTitle |
Initial depression and response to imipramine in agoraphobia.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.
|